Tegoprazan

• Description:

  A novel potent, highly selective, competitive and orally active inhibitor of gastric H+/K+-ATPase with IC50 of ranging 0.29-0.52 uM porcine, canine and human H+/K+-ATPases in vitro.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  387.387

• Molecular Formula:

  C20H19F2N3O3

• Notes:

  Research use only, not for human use.

• Receptor:

  Proton Pump

• CAS Number:

  942195-55-3